Loading…

Atrophic and Microcystic Limited Prostatic Adenocarcinomas

Atrophic carcinoma and microcystic carcinoma have previously been classified as variants of conventional acinar adenocarcinoma. In this article, we studied 4 cases of atrophic carcinoma and 4 cases of limited microcystic carcinoma. We found an incidence of 0.8% in 250 needle prostatic biopsies and 1...

Full description

Saved in:
Bibliographic Details
Published in:International journal of surgical pathology 2020-09, Vol.28 (6), p.584-589
Main Authors: Arista-Nasr, Julian, Martinez-Benitez, Braulio, Mendez-Cano, Victor, Albores-Saavedra, Jorge
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c318t-b22a7fd8d06866cd15a1a93c9edc27aac11282f50c5cd10d71c0d98c0d95167e3
container_end_page 589
container_issue 6
container_start_page 584
container_title International journal of surgical pathology
container_volume 28
creator Arista-Nasr, Julian
Martinez-Benitez, Braulio
Mendez-Cano, Victor
Albores-Saavedra, Jorge
description Atrophic carcinoma and microcystic carcinoma have previously been classified as variants of conventional acinar adenocarcinoma. In this article, we studied 4 cases of atrophic carcinoma and 4 cases of limited microcystic carcinoma. We found an incidence of 0.8% in 250 needle prostatic biopsies and 1.3% of atrophic carcinoma in 150 radical prostatectomies. Microcystic carcinomas were found in 3 prostatectomies (1.2%) and in 1 needle biopsy (0.67%). The useful histological criteria for atrophic carcinoma included the irregular disposition of the glands, infiltrative pattern, “rigid” luminal borders, and intraluminal secretions. Cytological changes included scant cytoplasm, nucleomegaly, hyperchromatic nuclei, and visible nucleoli. The glands of the microcystic carcinoma differ from the benign glands because the malignant ones show a markedly greater dilatation and exhibit rigidity of glandular lumens. In some cases of microcystic carcinoma, the nuclei were flattened, small, and hyperchromatic; therefore, they can be difficult to recognize as malignant.
doi_str_mv 10.1177/1066896920911087
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2385713859</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1066896920911087</sage_id><sourcerecordid>2424879928</sourcerecordid><originalsourceid>FETCH-LOGICAL-c318t-b22a7fd8d06866cd15a1a93c9edc27aac11282f50c5cd10d71c0d98c0d95167e3</originalsourceid><addsrcrecordid>eNp1kL1PwzAQxS0EoqWwM6FKLCwB3yXxB1tV8SUFwQBz5NoOpGriYidD_3sctYBUieXs8_vds_0IOQd6DcD5DVDGhGQSqQSggh-QMciMJpix_DDuo5wM-oichLCklCJDOCajFDFNmZRjcjvrvFt_1nqqWjN9rrV3ehO62Bd1U3fWTF-9C50aTmbGtk4rr-vWNSqckqNKrYI9260T8n5_9zZ_TIqXh6f5rEh0CqJLFoiKV0YYygRj2kCuQMlUS2s0cqU0AAqscqrzKFLDQVMjxVByYNymE3K19V1799Xb0JVNHbRdrVRrXR9KTEXOIRYZ0cs9dOl638bXlZhhJriUKCJFt1T8bAjeVuXa143ymxJoOeRa7ucaRy52xv2iseZ34CfICCRbIKgP-3frv4bfv_5-Rg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2424879928</pqid></control><display><type>article</type><title>Atrophic and Microcystic Limited Prostatic Adenocarcinomas</title><source>SAGE</source><creator>Arista-Nasr, Julian ; Martinez-Benitez, Braulio ; Mendez-Cano, Victor ; Albores-Saavedra, Jorge</creator><creatorcontrib>Arista-Nasr, Julian ; Martinez-Benitez, Braulio ; Mendez-Cano, Victor ; Albores-Saavedra, Jorge</creatorcontrib><description>Atrophic carcinoma and microcystic carcinoma have previously been classified as variants of conventional acinar adenocarcinoma. In this article, we studied 4 cases of atrophic carcinoma and 4 cases of limited microcystic carcinoma. We found an incidence of 0.8% in 250 needle prostatic biopsies and 1.3% of atrophic carcinoma in 150 radical prostatectomies. Microcystic carcinomas were found in 3 prostatectomies (1.2%) and in 1 needle biopsy (0.67%). The useful histological criteria for atrophic carcinoma included the irregular disposition of the glands, infiltrative pattern, “rigid” luminal borders, and intraluminal secretions. Cytological changes included scant cytoplasm, nucleomegaly, hyperchromatic nuclei, and visible nucleoli. The glands of the microcystic carcinoma differ from the benign glands because the malignant ones show a markedly greater dilatation and exhibit rigidity of glandular lumens. In some cases of microcystic carcinoma, the nuclei were flattened, small, and hyperchromatic; therefore, they can be difficult to recognize as malignant.</description><identifier>ISSN: 1066-8969</identifier><identifier>EISSN: 1940-2465</identifier><identifier>DOI: 10.1177/1066896920911087</identifier><identifier>PMID: 32233699</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Adenocarcinoma - diagnosis ; Adenocarcinoma - pathology ; Biopsy ; Biopsy, Needle ; Cancer surgery ; Humans ; Male ; Pathology ; Prostate cancer ; Prostatectomy ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - pathology ; Urological surgery</subject><ispartof>International journal of surgical pathology, 2020-09, Vol.28 (6), p.584-589</ispartof><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c318t-b22a7fd8d06866cd15a1a93c9edc27aac11282f50c5cd10d71c0d98c0d95167e3</cites><orcidid>0000-0002-8925-8651</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32233699$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arista-Nasr, Julian</creatorcontrib><creatorcontrib>Martinez-Benitez, Braulio</creatorcontrib><creatorcontrib>Mendez-Cano, Victor</creatorcontrib><creatorcontrib>Albores-Saavedra, Jorge</creatorcontrib><title>Atrophic and Microcystic Limited Prostatic Adenocarcinomas</title><title>International journal of surgical pathology</title><addtitle>Int J Surg Pathol</addtitle><description>Atrophic carcinoma and microcystic carcinoma have previously been classified as variants of conventional acinar adenocarcinoma. In this article, we studied 4 cases of atrophic carcinoma and 4 cases of limited microcystic carcinoma. We found an incidence of 0.8% in 250 needle prostatic biopsies and 1.3% of atrophic carcinoma in 150 radical prostatectomies. Microcystic carcinomas were found in 3 prostatectomies (1.2%) and in 1 needle biopsy (0.67%). The useful histological criteria for atrophic carcinoma included the irregular disposition of the glands, infiltrative pattern, “rigid” luminal borders, and intraluminal secretions. Cytological changes included scant cytoplasm, nucleomegaly, hyperchromatic nuclei, and visible nucleoli. The glands of the microcystic carcinoma differ from the benign glands because the malignant ones show a markedly greater dilatation and exhibit rigidity of glandular lumens. In some cases of microcystic carcinoma, the nuclei were flattened, small, and hyperchromatic; therefore, they can be difficult to recognize as malignant.</description><subject>Adenocarcinoma - diagnosis</subject><subject>Adenocarcinoma - pathology</subject><subject>Biopsy</subject><subject>Biopsy, Needle</subject><subject>Cancer surgery</subject><subject>Humans</subject><subject>Male</subject><subject>Pathology</subject><subject>Prostate cancer</subject><subject>Prostatectomy</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Urological surgery</subject><issn>1066-8969</issn><issn>1940-2465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kL1PwzAQxS0EoqWwM6FKLCwB3yXxB1tV8SUFwQBz5NoOpGriYidD_3sctYBUieXs8_vds_0IOQd6DcD5DVDGhGQSqQSggh-QMciMJpix_DDuo5wM-oichLCklCJDOCajFDFNmZRjcjvrvFt_1nqqWjN9rrV3ehO62Bd1U3fWTF-9C50aTmbGtk4rr-vWNSqckqNKrYI9260T8n5_9zZ_TIqXh6f5rEh0CqJLFoiKV0YYygRj2kCuQMlUS2s0cqU0AAqscqrzKFLDQVMjxVByYNymE3K19V1799Xb0JVNHbRdrVRrXR9KTEXOIRYZ0cs9dOl638bXlZhhJriUKCJFt1T8bAjeVuXa143ymxJoOeRa7ucaRy52xv2iseZ34CfICCRbIKgP-3frv4bfv_5-Rg</recordid><startdate>202009</startdate><enddate>202009</enddate><creator>Arista-Nasr, Julian</creator><creator>Martinez-Benitez, Braulio</creator><creator>Mendez-Cano, Victor</creator><creator>Albores-Saavedra, Jorge</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8925-8651</orcidid></search><sort><creationdate>202009</creationdate><title>Atrophic and Microcystic Limited Prostatic Adenocarcinomas</title><author>Arista-Nasr, Julian ; Martinez-Benitez, Braulio ; Mendez-Cano, Victor ; Albores-Saavedra, Jorge</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c318t-b22a7fd8d06866cd15a1a93c9edc27aac11282f50c5cd10d71c0d98c0d95167e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adenocarcinoma - diagnosis</topic><topic>Adenocarcinoma - pathology</topic><topic>Biopsy</topic><topic>Biopsy, Needle</topic><topic>Cancer surgery</topic><topic>Humans</topic><topic>Male</topic><topic>Pathology</topic><topic>Prostate cancer</topic><topic>Prostatectomy</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Urological surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arista-Nasr, Julian</creatorcontrib><creatorcontrib>Martinez-Benitez, Braulio</creatorcontrib><creatorcontrib>Mendez-Cano, Victor</creatorcontrib><creatorcontrib>Albores-Saavedra, Jorge</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of surgical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arista-Nasr, Julian</au><au>Martinez-Benitez, Braulio</au><au>Mendez-Cano, Victor</au><au>Albores-Saavedra, Jorge</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Atrophic and Microcystic Limited Prostatic Adenocarcinomas</atitle><jtitle>International journal of surgical pathology</jtitle><addtitle>Int J Surg Pathol</addtitle><date>2020-09</date><risdate>2020</risdate><volume>28</volume><issue>6</issue><spage>584</spage><epage>589</epage><pages>584-589</pages><issn>1066-8969</issn><eissn>1940-2465</eissn><abstract>Atrophic carcinoma and microcystic carcinoma have previously been classified as variants of conventional acinar adenocarcinoma. In this article, we studied 4 cases of atrophic carcinoma and 4 cases of limited microcystic carcinoma. We found an incidence of 0.8% in 250 needle prostatic biopsies and 1.3% of atrophic carcinoma in 150 radical prostatectomies. Microcystic carcinomas were found in 3 prostatectomies (1.2%) and in 1 needle biopsy (0.67%). The useful histological criteria for atrophic carcinoma included the irregular disposition of the glands, infiltrative pattern, “rigid” luminal borders, and intraluminal secretions. Cytological changes included scant cytoplasm, nucleomegaly, hyperchromatic nuclei, and visible nucleoli. The glands of the microcystic carcinoma differ from the benign glands because the malignant ones show a markedly greater dilatation and exhibit rigidity of glandular lumens. In some cases of microcystic carcinoma, the nuclei were flattened, small, and hyperchromatic; therefore, they can be difficult to recognize as malignant.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>32233699</pmid><doi>10.1177/1066896920911087</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-8925-8651</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1066-8969
ispartof International journal of surgical pathology, 2020-09, Vol.28 (6), p.584-589
issn 1066-8969
1940-2465
language eng
recordid cdi_proquest_miscellaneous_2385713859
source SAGE
subjects Adenocarcinoma - diagnosis
Adenocarcinoma - pathology
Biopsy
Biopsy, Needle
Cancer surgery
Humans
Male
Pathology
Prostate cancer
Prostatectomy
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - pathology
Urological surgery
title Atrophic and Microcystic Limited Prostatic Adenocarcinomas
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T10%3A16%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Atrophic%20and%20Microcystic%20Limited%20Prostatic%20Adenocarcinomas&rft.jtitle=International%20journal%20of%20surgical%20pathology&rft.au=Arista-Nasr,%20Julian&rft.date=2020-09&rft.volume=28&rft.issue=6&rft.spage=584&rft.epage=589&rft.pages=584-589&rft.issn=1066-8969&rft.eissn=1940-2465&rft_id=info:doi/10.1177/1066896920911087&rft_dat=%3Cproquest_cross%3E2424879928%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c318t-b22a7fd8d06866cd15a1a93c9edc27aac11282f50c5cd10d71c0d98c0d95167e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2424879928&rft_id=info:pmid/32233699&rft_sage_id=10.1177_1066896920911087&rfr_iscdi=true